David S. Fedor

NovaSterilis, Inc. develops and commercializes supercritical carbon dioxide technology for use in sterilization of biomedical materials. It offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone. The firm provides consumable supplies, such as gas permeable packaging, biological indicators, and NovaKill, a proprietary additive. The company was founded in 2000 and is headquartered in Lansing, NY.

NovaSterilis, Inc. develops and commercializes supercritical carbon dioxide technology for use in sterilization of biomedical materials. It offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone. The firm provides consumable supplies, such as gas permeable packaging, biological indicators, and NovaKill, a proprietary additive. The company was founded in 2000 and is headquartered in Lansing, NY.

NovaSterilis, Inc. develops and commercializes supercritical carbon dioxide technology for use in sterilization of biomedical materials. It offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone. The firm provides consumable supplies, such as gas permeable packaging, biological indicators, and NovaKill, a proprietary additive. The company was founded in 2000 and is headquartered in Lansing, NY.

NovaSterilis, Inc. develops and commercializes supercritical carbon dioxide technology for use in sterilization of biomedical materials. It offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone. The firm provides consumable supplies, such as gas permeable packaging, biological indicators, and NovaKill, a proprietary additive. The company was founded in 2000 and is headquartered in Lansing, NY.